Mixed results at Priceline, approval for Sandoz’s drugs, smoking impacts academic success, UNSW’s health hub opens, and more
Click here to download Pharmacy Daily for Thursday 29th August 2024
PARTNER SITES
Other recent headlines
-
MedAdvisor aces FY24
Friday | Aug 30 2024STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
-
Enhertu gets PBS listing
Friday | Aug 30 2024AUSTRALIANS with a newly defined type of metastatic breast cancer, HER2-low, will now have access to a life-prolonging drug under the PBS from 01 Sep.
-
Mixed results at Priceline
Thursday | Aug 29 2024WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
to top